Biotech merger creates £280m group

Two of the UK's richest biotech companies unveiled a surprise merger yesterday in a move hailed as a significant breakthrough for a sector long in need of consolidation.

Cambridge Antibody Technology is buying Oxford GlycoSciences in an all-share deal to create a £280m group developing new drugs for rheumatoid arthritis, cancer and allergies.

David Ebsworth, chief executive of OGS, won praise from investors for agreeing to give up the top job, breaking the mould of biotech bosses who have often been seen as putting egos in the way of consolidation.

After six months helping integrate the two loss-making companies, Mr Ebsworth will become a non-executive director of the enlarged CAT, which will have a cash pile of £260m to pursue new drug development work and to licence in new products.

CAT's shareholders will own 64 per cent of the combined company and Peter Chambré, its chief executive, will lead the enlarged group.

Mr Chambré said: "We are both highly regarded companies in the UK, but when you compare us to the top tier of global biopharmaceutical groups there is quite a gap. It is a gap which we wish to close and our ability to do that will be enhanced by this merger." He argued that drug discovery technologies at the core of the two companies would fit well together. OGS is an expert in proteomics, and as such is able to identify proteins in the human body which may be linked to disease. CAT's expertise is in the identification and manufacture of antibodies, which are formed in the human body to fight disease.

The merged group will have seven products being trialled on humans and another seven in pre-clinical development. Both companies also bring one finished product: CAT's Humira is a treatment for rheumatoid arthritis which is ready for launch in the US, and OGS's Zavesca treats Gaucher disease, a rare condition in which the body has difficulty breaking down fat. Zavesca is approved in Europe but has been held up by sceptical US regulators.

The group still needs to broaden that pipeline of drugs if it is to reach profitability within five years, as Mr Chambré has promised. Although CAT is now more likely to buy in individual products than other companies, he said further deals could be expected when OGS was integrated.

CAT is targeting £10m of annual cost savings from cutting administrative staff at OGS in Oxford and selling property. There will also be a cull of the least exciting drug development work to save further cash and the combined group is expected to have an annual cash burn of about £50m.

The biotech industry has fallen as dramatically from investor favour as internet companies. The UK sector has suffered a chronic shortage of funds and few investors believe many businesses will survive to turn a profit. CAT has tumbled from £29 at its peak and fell a further 40p to 500p yesterday. OGS is down from £48, but jumped 32.5p to 185p on news of the takeover.

The deal was sealed after CAT settled two long-standing patent disputes last month.

Start your day with The Independent, sign up for daily news emails
PROMOTED VIDEO
ebooks
ebooksA special investigation by Andy McSmith
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Software Development Manager

£40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...

Ashdown Group: Product Manager - (Product Marketing, Financial Services)

£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...

Recruitment Genius: Compliance Assistant

£13000 per annum: Recruitment Genius: This Pension Specialist was established ...

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Day In a Page

As in 1942, Germany must show restraint over Greece

As in 1942, Germany must show restraint over Greece

Mussolini tried to warn his ally of the danger of bringing the country to its knees. So should we, says Patrick Cockburn
Britain's widening poverty gap should be causing outrage at the start of the election campaign

The short stroll that should be our walk of shame

Courting the global elite has failed to benefit Britain, as the vast disparity in wealth on display in the capital shows
Homeless Veterans appeal: The rise of the working poor: when having a job cannot prevent poverty

Homeless Veterans appeal

The rise of the working poor: when having a job cannot prevent poverty
Prince Charles the saviour of the nation? A new book highlights concerns about how political he will be when he eventually becomes king

Prince Charles the saviour of the nation?

A new book highlights concerns about how political he will be when he eventually becomes king
How books can defeat Isis: Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad

How books can defeat Isis

Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad
Judith Hackitt: The myths of elf 'n' safety

Judith Hackitt: The myths of elf 'n' safety

She may be in charge of minimising our risks of injury, but the chair of the Health and Safety Executive still wants children to be able to hurt themselves
The open loathing between Barack Obama and Benjamin Netanyahu just got worse

The open loathing between Obama and Netanyahu just got worse

The Israeli PM's relationship with the Obama has always been chilly, but going over the President's head on Iran will do him no favours, says Rupert Cornwell
French chefs get 'le huff' as nation slips down global cuisine rankings

French chefs get 'le huff' as nation slips down global cuisine rankings

Fury at British best restaurants survey sees French magazine produce a rival list
Star choreographer Matthew Bourne gives young carers a chance to perform at Sadler's Wells

Young carers to make dance debut

What happened when superstar choreographer Matthew Bourne encouraged 27 teenage carers to think about themselves for once?
Design Council's 70th anniversary: Four of the most intriguing prototypes from Ones to Watch

Design Council's 70th anniversary

Four of the most intriguing prototypes from Ones to Watch
Dame Harriet Walter: The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment

Dame Harriet Walter interview

The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment
Art should not be a slave to the ideas driving it

Art should not be a slave to the ideas driving it

Critics of Tom Stoppard's new play seem to agree that cerebral can never trump character, says DJ Taylor
Bill Granger recipes: Our chef's winter salads will make you feel energised through February

Bill Granger's winter salads

Salads aren't just a bit on the side, says our chef - their crunch, colour and natural goodness are perfect for a midwinter pick-me-up
England vs Wales: Cool head George Ford ready to put out dragon fire

George Ford: Cool head ready to put out dragon fire

No 10’s calmness under pressure will be key for England in Cardiff
Michael Calvin: Time for Old Firm to put aside bigotry and forge new links

Michael Calvin's Last Word

Time for Old Firm to put aside bigotry and forge new links